Charles Rhyee
Stock Analyst at TD Cowen
(2.24)
# 2,323
Out of 4,479 analysts
40
Total ratings
42.31%
Success rate
-1.19%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON PLC | Maintains: Buy | $349 → $373 | $318.30 | +17.19% | 2 | May 31, 2024 | |
| MEDP Medpace Holdings | Initiates: Buy | $452 | $404.42 | +11.77% | 1 | May 29, 2024 | |
| FTRE Fortrea Holdings | Initiates: Hold | $27 | $23.80 | +13.45% | 1 | May 29, 2024 | |
| MDRX Veradigm | Maintains: Buy | $26 → $15 | $9.66 | +55.28% | 2 | May 28, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $7.82 | +104.60% | 7 | May 16, 2024 | |
| CRL Charles River Laboratories International | Maintains: Hold | $260 → $228 | $201.48 | +13.16% | 3 | May 13, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $16 → $15 | $9.40 | +59.57% | 4 | Apr 26, 2024 | |
| CAH Cardinal Health | Maintains: Market Perform | $88 → $90 | $96.54 | -6.77% | 1 | Aug 16, 2023 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.18 | +129.36% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $5 → $2.5 | $0.30 | +747.46% | 3 | Mar 23, 2023 | |
| VEEV Veeva Systems | Maintains: Market Perform | $184 → $189 | $182.85 | +3.36% | 2 | Mar 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Outperform | $251 | $207.47 | +20.98% | 1 | Dec 6, 2022 | |
| OWLT Owlet | Maintains: Outperform | $70 → $56 | $4.00 | +1,300.00% | 2 | Oct 20, 2022 | |
| DRIO DarioHealth | Maintains: Outperform | $18 → $14 | $1.18 | +1,086.44% | 3 | Aug 16, 2022 | |
| EVH Evolent Health | Maintains: Outperform | $48 → $50 | $19.25 | +159.74% | 1 | Jun 21, 2022 | |
| MCK McKesson | Maintains: Outperform | $325 → $361 | $584.83 | -38.27% | 2 | Apr 18, 2022 | |
| BTTX Better Therapeutics | Initiates: Outperform | n/a | $0.01 | - | 1 | Nov 10, 2021 | |
| OTRK Ontrak | Initiates: Outperform | n/a | $0.20 | - | 1 | Jul 16, 2020 | |
| PINC Premier | Initiates: Market Perform | n/a | $18.50 | - | 1 | Feb 13, 2018 |
ICON PLC
May 31, 2024
Maintains: Buy
Price Target: $349 → $373
Current: $318.30
Upside: +17.19%
Medpace Holdings
May 29, 2024
Initiates: Buy
Price Target: $452
Current: $404.42
Upside: +11.77%
Fortrea Holdings
May 29, 2024
Initiates: Hold
Price Target: $27
Current: $23.80
Upside: +13.45%
Veradigm
May 28, 2024
Maintains: Buy
Price Target: $26 → $15
Current: $9.66
Upside: +55.28%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $7.82
Upside: +104.60%
Charles River Laboratories International
May 13, 2024
Maintains: Hold
Price Target: $260 → $228
Current: $201.48
Upside: +13.16%
Teladoc Health
Apr 26, 2024
Maintains: Hold
Price Target: $16 → $15
Current: $9.40
Upside: +59.57%
Cardinal Health
Aug 16, 2023
Maintains: Market Perform
Price Target: $88 → $90
Current: $96.54
Upside: -6.77%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.18
Upside: +129.36%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $5 → $2.5
Current: $0.30
Upside: +747.46%
Veeva Systems
Mar 6, 2023
Maintains: Market Perform
Price Target: $184 → $189
Current: $182.85
Upside: +3.36%
IQVIA Holdings
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $207.47
Upside: +20.98%
Owlet
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $4.00
Upside: +1,300.00%
DarioHealth
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $1.18
Upside: +1,086.44%
Evolent Health
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $19.25
Upside: +159.74%
McKesson
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $584.83
Upside: -38.27%
Better Therapeutics
Nov 10, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.01
Upside: -
Ontrak
Jul 16, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.20
Upside: -
Premier
Feb 13, 2018
Initiates: Market Perform
Price Target: n/a
Current: $18.50
Upside: -